[Effect of a single dose of intravenous captopril in hypertensive subjects]. 1988

M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
January 1986, European journal of clinical pharmacology,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
July 1988, Journal of clinical pharmacology,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
April 1982, The American journal of cardiology,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
January 1986, Clinical and experimental hypertension. Part A, Theory and practice,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
June 1981, Archives des maladies du coeur et des vaisseaux,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
September 1986, Bollettino della Societa italiana di biologia sperimentale,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
January 1997, Journal of clinical pharmacology,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
November 1995, Journal of human hypertension,
M Franchi, and F Puccetti, and F Landini, and A Burresi, and T Di Perri
January 1981, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!